New insertion site for Nexplanon following safety concerns
The MHRA has amended its advice relating to the long-acting contraceptive implant Nexplanon (etonogestrel) following reports of neurovascular injury and implants migrating to the vasculature (including the pulmonary artery).
by Lisa Lytle
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.